/PRNewswire/ NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced the appointment of D. Gordon Strickland.
/PRNewswire/ NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced the appointment of D. Gordon Strickland.
BOSTON, Jan. 28, 2022 /PRNewswire/ NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company, today announced the appointment of D. Gordon Strickland to its Board of Directors,. | January 28, 2022
NeuroBo Pharmaceuticals Shareholders Elect Hyung Heon Kim and Andrew I Koven to NeuroBo s Board of Directors prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.